Actively Recruiting
SV2 PET Imaging With [11C]APP311
Led by Yale University · Updated on 2026-01-28
250
Participants Needed
1
Research Sites
469 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to evaluate a new SV2A tracer, \[11C\]APP311, in healthy aging and neuropsychiatric disorders including psychotic disorders and cannabis use disorders.
CONDITIONS
Official Title
SV2 PET Imaging With [11C]APP311
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing and able to give voluntary written informed consent
- Male and Female subjects, age 18 to 65 years, inclusive
You will not qualify if you...
- MRI metal exclusions and claustrophobia
- Education completed is less than 12 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Conneticut Mental Health Center
New Haven, Connecticut, United States, 06519
Actively Recruiting
Research Team
A
Angerlyk Frytz, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here